Top Markets
Coin of the day
Clinical Laserthermia Systems AB (publ) Clinical Laserthermia Systems AB (publ)

Clinical Laserthermia Systems AB (publ)

CLS-B
Rang in Aktien #16822
Clinical Laserthermia Systems AB (publ) develops treatment tools for diseased... Clinical Laserthermia Systems AB (publ) develops treatment tools for diseased tissue under the TRANBERG brand in Sweden. The company offers TRANBERG, a thermal therapy system designed to deliver laser energy to heat the target tissue. It also provides mobile laser unit, a controlling component with a wavelength of 1064 nanometers provides multiple options to control treatment. In addition, the company offers various gauge laser applicators, as well as provides temperature and treatment monitoring devices. Clinical Laserthermia Systems AB (publ) was incorporated in 2006 and is headquartered in Lund, Sweden.
Aktienkurs
$0.51099792
Marktkapitalisierung
$13.22M
Veränderung (1 Tag)
-0.54%
Veränderung (1 Jahr)
99.27%
Land
SE
Handel Clinical Laserthermia Systems AB (publ) (CLS-B)

Kategorie

P/B-Verhältnis für Clinical Laserthermia Systems AB (publ) (CLS-B)
P/B-Verhältnis zum April 2026 TTM: 1.99
Laut den neuesten Finanzberichten und dem Aktienkurs von Clinical Laserthermia Systems AB (publ) beträgt das aktuelle Kurs-Buchwert-Verhältnis (TTM) 1.99. Am Ende des Jahres 2023 lag das P/B-Verhältnis bei 2.03.
P/B-Verlauf für Clinical Laserthermia Systems AB (publ) von 2008 bis 2026
P/B-Verhältnis zum Jahresende
Jahr P/B-Verhältnis ändert
2026 (TTM) 1.99 237.56%
2024 0.59 -71.05%
2023 2.03 -73.67%
2022 7.69 -28.81%
2021 10.81 -26.23%
2020 14.65 -50.47%
2019 29.58 587.26%
2018 4.30 -67.02%
2017 13.05 -1.35%
2016 13.23 45.08%
2015 9.12 115.27%
2014 4.24 -59.57%
2013 10.48 -99.58%
2012 2.49K -55.39%
2011 5.57K -3.48%
2010 5.77K 38.40%
2009 4.17K 8,518.09%
2008 48.40 0.00%
P/B-Verhältnis für ähnliche Unternehmen oder Wettbewerber
Unternehmen P/B-Verhältnis P/B-Verhältnis-Differenz Land
3.438 72.63%
US
5.606 181.48%
US
2.2679 13.87%
IE
2.2679 13.87%
IE
3.8394 92.78%
US